Idenix Pharmaceuticals (IDIX) Misses Q4 EPS by 8c, Guides Below for FY
Tweet Send to a Friend
Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) reports a Q4 loss of $0.42, 8 cents worse than estimates ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
